drugset / Trial / NCT02456948
Adjunct Minocyline in Treatment-resistant Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
This study examines the antidepressant efficacy of minocycline as an adjunct to an antidepressant standard treatment (AD-ST), for patients with unipolar major depressive disorder (MDD).
Timeline
- Start
- 2015-01
- Primary completion
- 2020-08-07
- Completion
- 2020-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 200 mg | Oral |